News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Seven criteria to audit your CDMO partner before phase transitions
87% of biopharma companies outsource development or manufacturing. A practical framework for evaluating CDMO partners across lifecycle continuity, tech transfer maturity, and regulatory readiness.
Biologic drugs need better vials. Here's what matters.
Monoclonal antibodies and gene therapies dominate pharma pipelines, but their sensitivity to temperature, moisture, and light demands specialized containment. Learn what vial systems must deliver.
Simcere and Stanford develop first-in-class IPF drug candidate
Simcere Pharmaceutical partners with Stanford Medicine to fund research on a novel respiratory molecule for idiopathic pulmonary fibrosis, a progressive lung disease with median survival of three years post-diagnosis.
Four oncology drugs and diagnostics win FDA approval in one week
AstraZeneca's Truqap, Roche's PTEN test, Bayer's MRI agent, and MSD's Keytruda combo cleared. Here's what each does and who benefits.
UK approves nasal spray adrenaline for children aged 4+, sidestepping needle fears
The MHRA cleared a 1mg dose of EURneffy for children weighing 15–30kg. Needle-averse patients may now carry and self-administer adrenaline faster during anaphylaxis.
Three paths biotech companies take after rebrand
Galapagos, Hoth, and Molecular Health used name changes to signal different strategic moves: retreat from failure, pivot to growth, or focus on strength. Here's what each reveals about biotech restructuring.
Collagen Forms Liquid Droplets Inside Cells, Not Rigid Rods
Barcelona researchers used live-cell imaging to show collagen exists as oil-like condensates in the endoplasmic reticulum, challenging 50+ years of textbook dogma and opening new routes to target fibrosis and cancer.
Parabilis raises $770.5M in largest biotech IPO, beats Moderna's 2018 record
Parabilis Medicines priced its IPO at $770.5M gross, surpassing Kailera's $625M April offering and Moderna's $604M 2018 debut. The Cambridge biotech is advancing stabilized peptide drugs targeting historically undruggable cancer proteins.
AI Maps Drug Effects on Cell Structures to Predict Gene Regulation
Princeton researchers used deep learning to spot shape changes in cellular condensates that reveal how drugs affect gene regulation. The model discovered a new morphology pattern linked to DNA replication.
Biotech hiring stalls even as market recovers
Biotech revenue and funding are climbing back, but executive recruitment remains flat. Companies are waiting longer to fill leadership roles despite improved industry health.
Diabetes now triggers frozen shoulder in people as young as 40
Doctors across India report musculoskeletal disorders in younger diabetic patients than historically expected. High blood sugar damages tendons and nerves — here's what to watch for.
Wayanad Shigella outbreak stabilizes: 23 in treatment, no new cases
16 children confirmed with Shigella infection remain stable in Wayanad district. Health officials report no new cases Saturday but 538 symptomatic people identified so far.